About Concept Pharmaceuticals Limited
Data last updated:
Concept Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1979PLC021126. Its GSTIN is 27AAACC4440M1ZN (Maharashtra). The company holds 19 GST registrations, of which 13 are active.
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹12 Cr. It was formerly known as Concept Pharmaceuticals Private Limited. It is led by directors including Yugin Adhyatma Gupta and Ved Parkash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹222.11 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.62 Cr (net margin 1.2%) and EBITDA of ₹13.72 Cr (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The company has about 519 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Concept Pharmaceuticals. As per MCA filings, the company has open charges of ₹280.33 Cr and satisfied charges of ₹77.95 Cr on record. Court records list 303 cases involving the company, including 208 filed by the company and 85 filed against it; 74 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website conceptpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address801 – B Hubtown Solaris N.S. Phadke Marg Off. Teli Galli Near Andheri Flyover A, Ndheri (E), Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Concept Pharmaceuticals Limited
The main business activity of Concept Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Concept Pharmaceuticals Limited FY 2024 filings available
Concept Pharmaceuticals Limited reported revenue of ₹222.11 Cr (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Concept Pharmaceuticals Limited
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Concept Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹222.11 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.72 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.62 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Concept Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Concept Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Concept Pharmaceuticals Limited
Concept Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| DPB Pharmaceuticals Limited | ₹223.13 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | •••• | •••• | 48.0% | •••• | Solan, Himachal Pradesh, India |
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Concept Pharmaceuticals Limited this company | ₹222.11 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Mumbai, Maharashtra, India |
| Zyphar's Pharmaceutics Private Limited | ₹221.78 Cr (FY 2025) | •••• | •••• | 283.0% | •••• | Pune, Maharashtra, India |
| Krishna Solvechem Limited | ₹221.34 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Naprod Life Sciences Private Limited | ₹219.65 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Sava Healthcare Limited | ₹219.36 Cr (FY 2022) | •••• | •••• | 30.0% | •••• | Surendranagar, Gujarat, India |
| Makson Healthcare Private Limited | ₹217.91 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Mandideep, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Concept Pharmaceuticals by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Concept Pharmaceuticals Limited
Concept Pharmaceuticals Limited is audited by SANJAY P.MUTHE for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANJAY P.MUTHE | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Concept Pharmaceuticals Limited
Concept Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Adhyatma Gupta Also directs: Concept Laboratories Pvt Ltd, Dynamic Machines Private Limited, Jovial Realtors Private Limited and 2 more | Additional Director | 15 Jan 2025 | 1 Years 8 Months | Current |
| Yugin Adhyatma Gupta Also directs: Concept Laboratories Pvt Ltd, Dynamic Machines Private Limited, Jovial Realtors Private Limited and 4 more | Director | 01 Nov 2012 | 13 Years 11 Months | Current |
| Ved Parkash Kumar | Director | 29 Sep 1995 | 31 Years 0 Months | Current |
Ownership and Shareholding of Concept Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Concept Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2025 | Canara Bank | ₹49 Cr | Open |
| 14 Oct 2024 | Others | ₹2.5 Cr | Open |
| 27 Sep 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹3 Cr | Open |
| 18 Nov 2021 | Others | ₹3.73 Cr | Open |
| 12 Mar 2021 | Canara Bank | ₹43 Cr | Open |
Total charge records: 53 View all charges
Legal Cases of Concept Pharmaceuticals Limited
Concept Pharmaceuticals Limited has 303 court cases on record: 208 filed by Concept Pharmaceuticals, 85 filed against it, 10 where it is another party. 74 cases are pending and 229 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 193 | 55 | 58 |
| High courts | 110 | 30 | 16 |
Cases on record (5 of 303)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI BAIL APPLN) | Filed against the company by Manav Drugs Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI M A) | Filed against the company by Manav Drugs Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by Manav Drugs Private Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Concept Biosciences India Private Limited | Pending |
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by Innova Captab Limited | Disposed |
Full case history
All 303 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Concept Pharmaceuticals Limited
Concept Pharmaceuticals operates one associated brand: Concept Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical and animal health products with a focus on ethical and global operations. | conceptpharma.com |
Employees and EPFO Compliance at Concept Pharmaceuticals Limited
Concept Pharmaceuticals Limited has a workforce of 519 employees as of Mar 29, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Concept Pharmaceuticals Limited
Concept Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1979PTC021126. The current CIN is U24239MH1979PLC021126, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1979PLC021126 | Current |
| U24239MH1979PTC021126 | Previous |
Recent Activity on Concept Pharmaceuticals Limited
Concept Pharmaceuticals Limited has 6 board changes on record since 1995: 3 appointments and 3 cessations. The latest: Rekha Adhyatma Gupta was appointed as Additional Director on 15 Jan 2025.
80 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Concept Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Concept Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Concept Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Concept Pharmaceuticals Limited
Concept Pharmaceuticals has 19 GST registrations: 13 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC4440M1ZN | Maharashtra | Active | 01 Jul 2017 |
| 03AAACC4440M1ZX | Punjab | Active | 01 Jul 2017 |
| 05AAACC4440M1ZT | Uttarakhand | Active | 01 Jul 2017 |
| 06AAACC4440M1ZR | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Concept Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Concept Pharmaceuticals Limited
Concept Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 1979 (47+ years old) and is registered under CIN U24239MH1979PLC021126.
Concept Pharmaceuticals reported revenue of ₹222.11 Cr for FY 2024 (down 29% YoY).
Concept Pharmaceuticals has 3 current directors:
- Rekha Adhyatma Gupta - Additional Director
- Yugin Adhyatma Gupta - Director
- Ved Parkash Kumar - Director
Concept Pharmaceuticals reported a net profit of ₹2.62 Cr (net margin 1.2%) and EBITDA of ₹13.72 Cr (EBITDA margin 6.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Concept Pharmaceuticals is 3% over three years and 2% over five years. In the latest year (FY 2024) revenue fell 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Concept Pharmaceuticals is 27AAACC4440M1ZN, registered in Maharashtra. The company has 19 GST registrations in all, of which 13 are active and 6 are cancelled or inactive. Other active GSTINs include 03AAACC4440M1ZX (Punjab), 05AAACC4440M1ZT (Uttarakhand), 06AAACC4440M1ZR (Haryana).
The CIN (Corporate Identification Number) of Concept Pharmaceuticals is U24239MH1979PLC021126. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Concept Pharmaceuticals has 303 court cases on record: 208 filed by the company and 85 filed against it. 74 are pending. Most are in the district courts.
Concept Pharmaceuticals was incorporated on 20 March 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Concept Pharmaceuticals by revenue are Salvi Chemical Industries Limited, Aura Pharmaceuticals Private Limited, DPB Pharmaceuticals Limited, Venus Biosciences Private Limited, Nestor Pharmaceuticals Limited and 5 more, all in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals).
Rekha Adhyatma Gupta was appointed as Additional Director on 15 Jan 2025. Adhyatma Bandhu Gupta ceased to be Managing Director on 08 Jan 2025. Yugin Adhyatma Gupta ceased to be Additional Director on 30 Mar 2013. Concept Pharmaceuticals has 6 board changes on record in total.